Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + sulfadoxine/pyrimethamine for uncomplicated falciparum malaria in Pakistan
ACTRN12611001244998Phase 4Completed
- Sponsor
- Liaquat University of Medical and Health Sciences
- Start
- Jan 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate, sulfadoxine, pyrimethamine in malaria, Falciparum malaria (PF), sponsored by Liaquat University of Medical and Health Sciences. Started Jan 2011; status: completed.
02
Drugs
artesunatesulfadoxinepyrimethamine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12611001244998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001244998.